Anticancer agent xanthohumol inhibits IL-2 induced signaling pathways involved in T cell proliferation

Journal of Experimental Therapeutics and Oncology

Volumn 10, Issue 1, 2012, Pages 1-8

  Liu, Yongbo ^a   Gao, Xiaohua ^a   Deeb, Dorrah ^a   Arbab, Ali S ^a   Dulchavsky, Scott A ^a   Gauta, Subhash C ^a  

^a HENRY FORD HEALTH SYSTEM   (United States)

Author keywords

Erk1 2; IL 2; Jak STAT; Proliferation; Xanthohumol

Indexed keywords

CYCLIN D1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 2; JANUS KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MYC PROTEIN; PROTEIN C FOS; STAT PROTEIN; XANTHOHUMOL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL CYCLE PROGRESSION; CONTROLLED STUDY; DRUG EFFECT; LYMPHOCYTE PROLIFERATION; LYMPHOMA CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SPLEEN CELL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

ANIMALS; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CELL PROLIFERATION; FLAVONOIDS; GENE EXPRESSION REGULATION, NEOPLASTIC; INTERLEUKIN-2; JANUS KINASES; MAP KINASE SIGNALING SYSTEM; MICE; MICE, INBRED C57BL; PROPIOPHENONES; SPLEEN; T-LYMPHOCYTES;

EID: 84864414560     PISSN: 13594117     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Block, G., Patterson, B., Subar, A. Fruit, vegetables, and cancer prevention: a review of the epidemiological evidence. Nutr. Cancer 1992; 18: 1-29.
2. Hu, F. B., Stampfer, M. J., Manson, J. E., Rimm, E., Colditz, G. A., Rosner, B. A.; Hennekens, C. H.; Willett, W. C. Dietary fat intake and the risk of coronary heart disease in women. N. Engl. J. Med. 1997; 337: 1491-1499. (Pubitemid 27495774)
3. Surh, Y. Molecular mechanisms of chemopreventive effects of selected dietary and medicinal phenolic substances. Mutat. Res. 1999; 428: 305-327. (Pubitemid 29389702)
4. Stevens, J. F., Taylor, A. W., Deinzer, M. L. Quantitative analysis of xanthohumol and related prenylflavonoids in hops and beer by liquid chromatography-tandem mass spectrometry. J. Chromatogr A. 1999; 832: 97-107. (Pubitemid 29073728)
5. Stevens, J. F., Page, J. E. Xanthohumol and related prenylflavonoids from hops and beer: to your good health! Phytochemistry 2004; 65: 1317-1330. (Pubitemid 38844716)
6. Gerhauser, C., Alt, A., Heiss, E., Gamal-Eldeen, A., Klimo, K., Knauft, J., Neumann, I., Scherf, H. R., Frank, N., Bartsch, H., Becker, H. Cancer chemopreventive activity of Xanthohumol, a natural product derived from hop. Mol. Cancer Ther. 2002; 1: 959-969.
7. Miranda, C. L., Aponso, G. L., Stevens, J. F., Deinzer, M. L., Buhler, D. R. Prenylated chalones and flavanones as inducers of quinine reductase in mouse 1c7 cells. Cancer Lett. 2000; 149: 21-29. (Pubitemid 30100556)
8. Dietz, B. M., Kang, Y. H., Liu, G., Eggler, A. L., Yao, P., Chadwick, L. R., Pauli, G. F., Farnsworth, N. R., Mesecar, A. D., van Breemen, R. B., Bolton, J. L. Xanthohumol isolated from Humulus lupulus inhibits menadione-induced DNA damage through induction of quinone reductase. Chem Res Toxicol. 2005; 18: 1296-1305. (Pubitemid 41170254)
9. Miranda, C. L., Stevens, J. F., Helmrich, A., Henderson, M. C., Rodriguez, R. J., Yang, Y. H., Deinzer, M. L., Barnes, D. W., Buhler, D. R. Antiproliferative and cytotoxic effects of prenylated flavonoids from hops (Humulus lupulus) in human cancer cell lines. Food Chem Toxicol. 1999; 37: 271-285. (Pubitemid 29335754)
10. Delmulle, L., Bellahcene, A., Dhooge, W., Comhaire, F., Roelens, F., Huvaere, K., Heyerick, A., Castronovo, V., De Keukeleire, D. Anti-proliferative properties of prenylated flavonoids from hops (Humulus lupulus L.) in human prostate cancer cell lines. Phytomedicine 2006; 13: 732-734. (Pubitemid 44666399)
11. Colgate, E. C., Miranda, C. L., Stevens, J. F., Bray, T. M., Ho, E. Xanthohumol, a prenylflavonoid derived from hops induces apoptosis and inhibits NF-kappaB activation in prostate epithelial cells. Cancer Lett. 2006; 246: 201-209.
12. Vanhoecke, B., Derycke, L., Van Marck, V., Depypere, H., De Keukeleire, D., Bracke M. Antiinvasive effect of xanthohumol, a prenylated chalcone present in hops (Humulus lupulus L.) and beer. Int. J. Cancer 2005; 117: 889-895. (Pubitemid 41688562)
13. Albini, A., Dell'Eva, R., Vene, R., Ferrari, N., Buhler, D. R., Noonan, D. M., Fassina, G. Mechanisms of the antiangiogenic activity by the hop flavonoid xanthohumol: NFkappaB and Akt as targets. FASEB J. 2006; 20: 527-529. (Pubitemid 46671238)
14. Lee, S. H., Kim, H. J., Lee, J. S., Lee, I. S., Kang, B. Y. Inhibition of topoisomerase 1 activity and efflux drug transporter's expression by xanthohumol from hops. Arch. Pharm. Res. 2007; 30: 1435-1439.
15. Monteiro, R., Faria, A., Azevedo, I., Calhau, C. Modulation of breast cancer cell survival by aromatase inhibiting hop (Humulus lupus L.) flavonoids. J. Steroid Bioche. Mol. Biol. 2007; 105: 124-130. (Pubitemid 47211960)
16. Zhao, F., Nozawa, H., Daikonnya, A., Kondo, K., Kitanaka, S. Inhibitors of nitric oxide production from hops (Humulus lupulus L.). Biol Pharm Bull. 2003; 26: 61-65. (Pubitemid 39663644)
17. Cho Y. C., Kim H. J., Kim Y. J., Lee K. Y., Choi H. J., Lee I. S., Kang B. Y. Differential anti-inflammatory pathway by xanthohumol in IFN-gamma and LPS-activated macrophages. Int. Immunopharmacol. 2008; 8: 567-73.
18. Gao, X., Deeb, D., Liu, Y, Gautam, S., Dulchavsky, S. A., Gautam, S. C. Immunomodulatory activity of xanthohumol: inhibition of T cell proliferation, cell-mediated cytotoxicity and Th1 cytokine production through suppression of NF-kB. Immunopharm. Immunotox. 2009; 31: 477-484.
19. Miyazaki, T., Kawahara, A., Fujii, H., Nakagawa, Y., Minami, Y., Liu, Z. J., Oishi, I., Silvennoinen, O., Witthuhn, B. A., Ihle, J. N., et al. Functional activation of Jak1 and Jak3 by selective association with IL-2 receptor subunits. Science, 1994; 266: 1045-1047. (Pubitemid 24373722)
20. Lin, J. X., Leonard, W. J. The role of Stat5a and Stat5b in signaling by IL-2 family cytokines. Oncogene., 2000; 2566-2576. (Pubitemid 30339212)
21. Ihle, J. N., Witthuhn, B. A., Quelle, F. W., Yamamoto, K., Thierfelder, W. E., Kreider, B., Silvennoinen, O. Signaling by the cytokine receptor superfamily: JAKs and STATs. Trends Biochem Sci. 1994; 19: 222-227. (Pubitemid 24187246)
22. Darnell, J. E. Stats and gene regulation. Science 1997; 277: 1630-1635.
23. Miranda, C. L., Stevens, J. F., Ivanov, V., McCall, M., Frei, B., Deinzer, M. L., Buhler D. R. Antioxidant and prooxidant actions of prenylated and nonprenylated chalcones and flavanones in vitro. J. Agric. Food Chem. 2000; 48: 3876-3884.
24. Smith, K. A. Interleukin 2. Annu Rev Immunol. 1984; 2: 319-233.
25. Malek, T. R., Castro, I. Interleukin-2 receptor signaling: at the interface between tolerance and immunity. Immunity 2010; 33: 153-165.
26. Benczik, M., Gaffen, S. L. The interleukin (IL)-2 family cytokines: survival and proliferation signaling pathways in T lymphocytes. Immunol. Invest. 2004; 33: 109-142. (Pubitemid 38685927)
27. Beadling, C., Guschin, D., Witthuhn, B. A., Ziemiecki, A., Ihle, J. N., Kerr, I. M., Cantrell, D. A. Activation of JAK kinases and STAT proteins by interleukin-2 and interferon alpha, but not the T cell antigen receptor, in human T lymphocytes. EMBO J. 1994; 13: 5605-5615. (Pubitemid 24363028)
28. Liu, K. D., Gaffen, S. L., Goldsmith, M. A., Greene, W. C. Janus kinases in interleukin-2 -mediated signaling: Jak1 and Jak3 are differentially regulated by tyrosine phosphorylation. Curr. Biol. 1997; 817-826. (Pubitemid 27493120)
29. Zhu, M. H., Berry, J. A., Russell, S. M. Leonard, W. J. Delineation of the regions of interleukin-2 (IL-2) receptor beta chain important for association of Jak1 and Jak3. Jak1-independent functional recruitment of Jak3 to IL-2Rbeta. J. Biol. Chem. 1998, 273: 10719-10725. (Pubitemid 28227687)
30. Lord, J. D., McIntosh, B. C., Greenberg, P. D., Nelson, B. H. The IL-2 receptor promotes lymphocyte proliferation and induction of the c-Myc, bcl-2, and bcl-x genes through the trans-activation domain of Stat5. J Immunol. 2000; 164: 2533-2541. (Pubitemid 30115483)
31. Nielsen, M., Svejgaard, A., Skov, S., Odum, N. Interleukin-2 induces tyrosine phosphorylation and nuclear translocation of stat3 in human T lymphocytes. Eur J Immunol. 1994; 24: 3082-3086.
32. Motegi, H., Shimo, Y., Akiyama, T., Inoue, J. TRAF6 negatively regulates the Jak1-Erk pathway in interleukin-2 signaling. Genes Cells. 2011; 16: 179-189.
33. Ravichandran, K. S., Burakoff, S. J. The adapter protein Shc interacts with the interleukin-2 (IL-2) receptor upon IL-2 stimulation. J Biol Chem. 1994; 269: 1599-1602. (Pubitemid 24035345)
34. Moriggl, R., Topham, D. J., Teglund, S., Sexl, V., McKay, C., Wang, D., Hoffmeyer, A., van Deursen, J., Sangster, M. Y., Bunting, K. D., Grosveld, G. C., Ihle, J. N. Stat5 is required for IL-2-induced cell cycle progression of peripheral T cells. Immunity 1999; 10: 249-259 (Pubitemid 29115630)
35. Nosaka, T., Kawashima, T., Misawa, K., Ikuta, K., Mui, A. L., Kitamura, T. STAT5 as a molecular regulator of proliferation, differentiation and apoptosis in hematopoietic cells. EMBO J. 1999; 18: 4754-4765. (Pubitemid 29415529)